Pedro Marín Selected Research

difloxacin

4/2011	Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats.
6/2006	Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Marín Research Topics

Disease

6	Bacterial Infections (Bacterial Infection) 05/2022 - 06/2006
4	Multiple Myeloma 04/2021 - 09/2016
3	Lymphoma (Lymphomas) 04/2021 - 09/2016
3	Crohn Disease (Crohn's Disease) 10/2017 - 01/2016
2	Mastitis 01/2020 - 04/2011
2	Fever (Fevers) 01/2020 - 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2022
1	Pneumonia (Pneumonitis) 02/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Mucositis 01/2016
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Body Weight (Weight, Body) 12/2009
1	Multiple Sclerosis 03/2003
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2002
1	Residual Neoplasm 07/2002
1	Infections 07/2002
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2002

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 01/2020
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2002
2	MacrolidesIBA 05/2022 - 04/2022
2	20,23- dipiperidinyl- mycaminosyl- tylonolideIBA 04/2022 - 08/2020
2	FluoroquinolonesIBA 02/2022 - 01/2020
2	plerixafor FDA Link 04/2021 - 09/2016
2	difloxacinIBA 04/2011 - 06/2006
1	tylvalosinIBA 05/2022
1	delafloxacinIBA 02/2022
1	Cefonicid (Monocid)FDA Link 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	NucleosidesIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	pomalidomideIBA 01/2018
1	AnthracyclinesIBA 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 10/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 11/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	EnrofloxacinIBA 12/2009
1	danofloxacinIBA 12/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2002

Therapy/Procedure

7	Stem Cell Transplantation 01/2020 - 01/2002
4	Therapeutics 01/2019 - 03/2003
2	Patient Readmission 01/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2018 - 09/2016
2	Transplantation 09/2016 - 07/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2003 - 07/2002
1	Antibiotic Prophylaxis 01/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Photopheresis 01/2019